Polaryx Therapeutics, Inc. PLYX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | -$27.82M+8.4% | ||
| —— | —— | —— | —— | $6.25M+160% | ||
| —— | —— | —— | —— | -$317.75K+20.8% | ||
| —— | -$66K— | —— | —— | —— | ||
| —— | —— | —— | —— | -$2.64M-2.6% | ||
| —— | —— | —— | —— | $5.74M-21.6% | ||
| —— | —— | —— | —— | $5.64M-21.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -$39K+53.7% | -$84.25K+34.9% | -$129.5K+25.9% | -$174.75K+20.6% | ||
| $39.25K+70.7% | $23K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $27K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Polaryx Therapeutics, Inc. generate?
- Polaryx Therapeutics, Inc. (PLYX) generated -$4.1M in operating cash flow over the trailing twelve months.
- Where does Polaryx Therapeutics, Inc. 's cash flow data come from?
- Every line is extracted from Polaryx Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.